SARASOTA, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
SARASOTA, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
SARASOTA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE: OGEN) (“Oragenics” or the “Company”), a company focused on developing unique, intranasal pharmaceuticals for the...
SARASOTA, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0001 | -25 | 0.0004 | 0.0004 | 0.0002 | 32832564 | 0.00031597 | CS |
4 | 0 | 0 | 0.0003 | 0.0004 | 0.0002 | 26667633 | 0.00033402 | CS |
12 | -0.0002 | -40 | 0.0005 | 0.0005 | 0.0002 | 55558377 | 0.00033365 | CS |
26 | -0.0002 | -40 | 0.0005 | 0.0005 | 1.0E-6 | 58766998 | 0.00034817 | CS |
52 | -0.0003 | -50 | 0.0006 | 0.0007 | 1.0E-6 | 80807193 | 0.00043284 | CS |
156 | -0.0084 | -96.5517241379 | 0.0087 | 0.0135 | 1.0E-6 | 127772901 | 0.00238888 | CS |
260 | 0.0002 | 200 | 0.0001 | 0.0198 | 1.0E-6 | 168896567 | 0.00306451 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.